Gennex Laboratories Rights Issue Details 2022, Entitlement, Record Date
Last updated August 22, 2026
This IPO News reference page covers “Gennex Laboratories Rights Issue Details 2022, Entitlement, Record Date”. The page is organized around gennex laboratories ltd rights issue details, gennex laboratories ltd rights issue dates, gennex laboratories ltd rights issue objective, company financials, about company. IPO News presents the structured facts and tables in its own layout and wording.
Topics Covered
- Gennex Laboratories Ltd Rights Issue Details
- Gennex Laboratories Ltd Rights Issue Dates
- Gennex Laboratories Ltd Rights Issue Objective
- Company Financials
- About Company
- Company Address
- Gennex Laboratories Lead Manager
- Gennex Laboratories RI Registrar
Key Facts
- India's trusted financial research platform since 2015. Live IPO GMP, subscription data, allotment status, Rights Issues, NCDs and unbiased stock broker reviews.
- The company has been providing services in the Indian market for the past 20 years. It is ready to set up another facility in Hyderabad with Major Regulatory Market approvals such as USFDA, COFEPRIS, TGA, and EDQM.
Data Tables
| Issue Size (Shares) | 6.32 Cr Shares |
|---|---|
| Issue Size (Amount) | ₹37.95 Cr |
| Face Value | ₹1 Per Share |
| Issue Price | ₹6 per share |
| Record Date | 22nd Jul 2022 |
| Listing At | BSE |
| BSE Code | 531739 |
| Letter of Offer | |
| Online Application (Registrar & Transfer Agent) | |
| Entitlement | 1 Rights Equity Share for every 2 Equity Shares held on the Record Date |
| Terms of payment | ₹1.50/- per Equity Shares to be paid on application and remaining ₹4.50/- per on First and Final Call. |
Source record: View original public source ↗